Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 807 results for "Treatment For Multiple Sclerosis"

Earlier MS treatment urged by charity

Earlier MS treatment urged by charity

People with the most common form of multiple sclerosis should be offered drug treatment earlier, a charity says. The Multiple Sclerosis Society's report suggests there is a "wait-and-see" approach by doctors which needs to end. But drug watchdog ... BBC, 5 days ago
Roche surges ahead in race for MS treatment Trade Arabia, 6 days ago

More Than 50 Presentations Of New Data From Genzyme's Multiple Sclerosis Franchise To Be Featured At ECTRIMS

Genzyme , a Sanofi company, announced today that new investigational data on its marketed treatments, Aubagio ® (teriflunomide) and Lemtrada ® (alemtuzumab), as well as data from the company's MS pipeline, will be presented during the 31 st ...
 TheStreet.com1 week ago
Irish Medical Times

Overview of Disease-Modifying Treatments in Multiple Sclerosis

Download PDF Diagnosis of Multiple Sclerosis Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating, degenerative disease of the central nervous system (CNS). During the early phases of the disease, the integrity of the ...
 Irish Medical Times4 days ago FDA Issues Approval For Bayer Autoinjector For Multiple Sclerosis Therapy  Tech Times1 week ago Researchers Reveal Treatment for Rare Brain Disease  Laboratory Equipment1 week ago Vaccination on the horizon for severe viral infection of the brain  Universität Zürich1 week ago
American Council On Science & Health

Groundbreaking Drug Has Huge Potential for MS Sufferers

There could be a substantial advance in the treatment of multiple sclerosis (MS) on the horizon. An possibly anunprecedented advance, at that. MS is an autoimmune disease, in which the myelin sheath (the cover of nerve cells) is attacked by the ...
 American Council On Science & Health6 days ago Status Update on MS Biomarkers (CME/CE)  MedPage Today6 days ago US Navy buys Israeli brain zapper to treat vets  The Times Of Israel2 weeks ago How one neurologist diagnosed with...  LocalNews7.com2 weeks ago
Reuters India

Novartis buys remaining rights to GSK treatment in deal up to $1 bn

said it had agreed to buy all remaining rights to Ofatumumab, which is being developed for relapsing remitting multiple sclerosis and other autoimmune indications. ZURICH: Novartis has agreed to buy all remaining rights to Ofatumumab from Britain's ...
 Economic Times1 month ago Novartis, Amgen join forces to fight Alzheimer's and migraine  Reuters India1 month ago Novartis : buys remaining rights to GSK treatment in deal up to $1 billion  4 Traders1 month ago Novartis To Buy Rest Of Rights To GSK's Auto-immune Drug Ofatumumab For $1 Bln  RTTNews.com1 month ago

Novartis Acquires Rights to GSK's Ofatumumab Drug For Multiple Sclerosis Treatment

Novartis, a Swiss multinational pharmaceutical company, based in Switzerland, has purchased the rights to a multiple sclerosis medication from British pharmaceutical giant GlaxoSmithKline (GSK). According to sources, the Swiss pharma will handle ...
 MedIndia1 month ago

Austrian's plea against deportation unbelievable, HC told

An Austrian citizen's plea against deportation citing ongoing Ayurvedic treatment for multiple sclerosis at Thiruvananthapuram was unbelievable, an inquiry conducted by ministry of home afairs has concluded.
 Times of India2 months ago

Pfizer Grabs Commercialization Rights of Potential MS Generic Treatment Glatiramer Acetate

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis Synthons glatiramer acetate, a potential generic version of Copaxone1 for the treatment of relapsing remitting multiple sclerosis ...
 BioSpace2 months ago Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis  Noodls2 months ago Pfizer : and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis  4 Traders2 months ago
Health Canal

Latest research on cognitive dysfunction in Multiple Sclerosis patients an eye opener

In a paper published in Nature Reviews Neurology, researchers at Monash University have revealed that eye movement measures can help identify the presence and progression of Multiple Sclerosis (MS). MS is a chronic disease of the central nervous ...
 Health Canal5 days ago New Research to Speed Up Treatments for Multiple Sclerosis  ALNMag.com1 month ago

Novartis buys rights to GSK MS drug for up to $1 billion

Novartis has added to its burgeoning multiple sclerosis portfolio with the $300 million acquisition of all outstanding rights to GlaxoSmithKline's Ofatumumab antibody. This Swiss company had previously acquired the rights to Ofatumumab for ...
 Pharmafile1 month ago Novartis acquires drug to develop treatment for MS  European Pharmaceutical Manufacturer4 weeks ago Novartis to acquire rights to Glaxo MS treatment  TeleTrader.com1 month ago Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications  EuroInvestor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
Get updated on latest news & your favorite topics right in your inbox!
More     Less